HL 301 in the treatment of acute bronchitis : a phase 2 b , randomized , double-blind , placebo-controlled , multicenter study

1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul; 2Department of Pulmonology and Critical Care Medicine, Kyung Hee University School of Medicine, Seoul; 3Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul; 4Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon; 5Department of Internal Medicine, Korea University College of Medicine, Seoul; 6Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon; 7Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea

[1]  Min-Hye Kim,et al.  Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough , 2017, The Korean journal of internal medicine.

[2]  C. Rhee,et al.  Efficacy and safety of HL301 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase 2, randomized, double-blind, placebo-controlled, multicenter study , 2017, Current medical research and opinion.

[3]  A. Qaseem,et al.  Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults , 2016, Annals of Internal Medicine.

[4]  J. Park,et al.  Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection , 2016, PloS one.

[5]  K. McGrail,et al.  Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections , 2016, Antimicrobial Agents and Chemotherapy.

[6]  A. Qaseem,et al.  Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention , 2016, Annals of Internal Medicine.

[7]  D. Kim,et al.  The Korean Cough Guideline: Recommendation and Summary Statement , 2015, Tuberculosis and respiratory diseases.

[8]  K. Yoo,et al.  Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea , 2015, Journal of Korean medical science.

[9]  Miran Kim,et al.  The effects of the standardized herbal formula PM014 on pulmonary inflammation and airway responsiveness in a murine model of cockroach allergen-induced asthma. , 2014, Journal of ethnopharmacology.

[10]  K. Nicholson,et al.  Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample , 2014, Journal of Infection.

[11]  Hwan-Suck Chung,et al.  Thirteen-Week Study of PM014 Subchronic Oral Toxicity in Rats , 2014, Evidence-based complementary and alternative medicine : eCAM.

[12]  Miran Kim,et al.  The standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease , 2013, BMC Complementary and Alternative Medicine.

[13]  H. Goossens,et al.  Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. , 2013, The Lancet. Infectious diseases.

[14]  Y. Jang,et al.  Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.

[15]  S. Nseir,et al.  Factors Predicting Bacterial Involvement in Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2008, Respiration.

[16]  S. Pearson,et al.  A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. , 2005, Chest.

[17]  T. Fahey,et al.  Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. , 2005, JAMA.